• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 25VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Ventricular Fibrillation (2130); Cardiac Tamponade (2226); Pericardial Effusion (3271); Convulsion/Seizure (4406); Thrombosis/Thrombus (4440)
Event Date 03/01/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 25mm sjm masters series valsalva aortic valved graft was implanted into a patient.After the procedure, the patient had increased drainage, clots, and a hematoma.A thoracotomy was performed and the tamponade decompressed.In addition, the patient was transfused plasma.The patient had ventricular fibrillation.Defibrillation was administered twice.On (b)(6) 2023, seizure was observed with the following symptoms: tremor of the left limbs, nystagmus, the left lower limb and upper limbs moved spontaneously, the right limbs did not move.The patient was diagnosed with cytotoxic edema in the course of ischemic changes in the acute phase.Medication was administered and the patient was transfused red blood cells.It was noted that the patient had low levels of fibrinogen.The device remained implanted and was reportedly working as intended.The patient was reported to be in stable condition.
 
Event Description
Crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 25mm sjm masters series valsalva aortic valved graft was implanted into a patient.After the procedure, the patient had increased drainage, clots, and a hematoma.A thoracotomy was performed and the tamponade decompressed.In addition, the patient was transfused plasma.The patient had ventricular fibrillation.Defibrillation was administered twice.On (b)(6) 2023, seizure was observed with the following symptoms: tremor of the left limbs, nystagmus, the left lower limb and upper limbs moved spontaneously, the right limbs did not move.The patient was diagnosed with cytotoxic edema in the course of ischemic changes in the acute phase.Medication was administered and the patient was transfused red blood cells.It was noted that the patient had low levels of fibrinogen.The device remained implanted and was reportedly working as intended.The patient was reported to be in stable condition.Subsequent to the previously filed report, additional information was received that on (b)(6) 2023, the patient was transfused with red blood cells.On (b)(6) 2023, it was noted that the patient fluid present in the right pleural cavity.The decision was made to perform a surgical puncture and drainage of 1000 ml serious bloody fluid.
 
Manufacturer Narrative
An event of presence of increased drainage, clots, a hematoma , pericardial effusion and tamponade was reported.A returned device assessment could not be performed as the device remains implants was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the reported event was not device related and that there was no allegation of malfunction against the abbott device.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16619367
MDR Text Key312124375
Report Number2135147-2023-01353
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009492
UDI-Public05414734009492
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/01/2023
Device Model Number25VAVGJ-515
Device Catalogue Number25VAVGJ-515
Device Lot Number8261271
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age49 YR
Patient SexMale
Patient Weight68 KG
Patient RaceWhite
-
-